Phase II Multicenter Study of Olaparib or Olaparib and MEDI 4736 in Platinum Treated Triple Negative Breast Cancer

Principal Investigator

Prof Rebecca Dent

Deputy Chief Executive Officer (Clinical) & Senior Consultant

Organised By

Conditions & Treatments

  • Breast Cancer

Specialty

  • Oncology

Published Date

20/10/2020

Study Description

Inoperable LA/MBC, TNBC

Last Updated: 20 October 2020